Literature DB >> 1327485

Lymphatic flow in carcinoma of the head of the pancreas.

M Kayahara1, T Nagakawa, H Kobayashi, K Mori, T Nakano, N Kadoya, T Ohta, K Ueno, I Miyazaki.   

Abstract

The lymphatic pathway from the head of the pancreas to the para-aortic lymph nodes was examined on the basis of the frequency of lymph node involvements. Forty-four patients were examined. All patients had extended radical operations. Thirty-one of 44 (70.5%) patients had lymph node involvement. The lymph nodes that had a high metastatic rate included the following: (1) lymph nodes around the common hepatic artery (number 8 lymph node); (2) lymph nodes of the hepatoduodenal ligament (number 12 lymph node); (3) the posterior pancreaticoduodenal lymph node (number 13 lymph node); (4) lymph nodes around the superior mesenteric artery (number 14 lymph node); (5) para-aortic lymph nodes (number 16 lymph node); and (6) the anterior pancreaticoduodenal lymph node (number 17 lymph node). Twenty-eight of these 31 patients had disease in the posterior pancreaticoduodenal lymph node. The patterns of lymph node involvement consisted of four combinations: number 13-number 17, number 13-number 14, number 14-number 16, and number 17-number 8. All of the patients with number 16 nodal involvement had number 14 lymph node metastasis. However, there was no relationship between tumor size and lymph node involvement. Based on these results, the main lymphatic pathway from the head of the pancreas to the para-aortic lymph nodes was thought to be via the lymph nodes around the superior mesenteric artery, assuming that lymphatic flow is anterograde. In addition, this study demonstrates that it is necessary to perform an extensive lymph node dissection, including the para-aortic lymph node, even in patients with small tumors.

Entities:  

Mesh:

Year:  1992        PMID: 1327485     DOI: 10.1002/1097-0142(19921015)70:8<2061::aid-cncr2820700808>3.0.co;2-v

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  26 in total

Review 1.  Oncological problems in pancreatic cancer surgery.

Authors:  Akimasa Nakao; Tsutomu Fujii; Hiroyuki Sugimoto; Naohito Kanazumi; Shuji Nomoto; Yasuhiro Kodera; Soichiro Inoue; Shin Takeda
Journal:  World J Gastroenterol       Date:  2006-07-28       Impact factor: 5.742

2.  Can intestinal innervation be preserved in pancreatoduodenectomy for cancer? Results of an anatomical study.

Authors:  M Nano; H Dal Corso; M Ferronato; M Solej; J P Hornung
Journal:  Surg Radiol Anat       Date:  2003-02-25       Impact factor: 1.246

3.  Does extended pancreaticoduodenectomy increase operative morbidity and mortality vs. standard pancreaticoduodenectomy?

Authors:  C Iacono; L Bortolasi; E Facci; G Falezza; G Prati; G Mangiante; G Serio
Journal:  J Gastrointest Surg       Date:  1997 Sep-Oct       Impact factor: 3.452

4.  Extended lymphadenectomy in pancreatic cancer is crucial.

Authors:  Tsutomu Fujii
Journal:  World J Surg       Date:  2013-08       Impact factor: 3.352

5.  The role of hepatic artery lymph node in pancreatic adenocarcinoma: prognostic factor or a selection criterion for surgery.

Authors:  Prejesh Philips; Erik Dunki-Jacobs; Steven C Agle; Charles Scoggins; Kelly M McMasters; Robert C G Martin
Journal:  HPB (Oxford)       Date:  2014-08-15       Impact factor: 3.647

Review 6.  Modern surgical treatment of pancreatic cancer.

Authors:  H Ozaki
Journal:  Int J Pancreatol       Date:  1994 Oct-Dec

7.  Results of pancreaticoduodenectomy for pancreatic cancer: extended versus standard procedure.

Authors:  Calogero Iacono; Simone Accordini; Luca Bortolasi; Enrico Facci; Giuseppe Zamboni; Ettore Montresor; Peter Domenico Marinello; Giovanni Serio
Journal:  World J Surg       Date:  2002-09-26       Impact factor: 3.352

8.  Hepatic arterial nodal metastases in pancreatic cancer: is this the node of importance?

Authors:  J LaFemina; J F Chou; M Gönen; F G Rocha; C Correa-Gallego; T P Kingham; Y Fong; M I D'Angelica; W R Jarnagin; R P DeMatteo; P J Allen
Journal:  J Gastrointest Surg       Date:  2013-04-16       Impact factor: 3.452

9.  Proposing the lymphatic target volume for elective radiation therapy for pancreatic cancer: a pooled analysis of clinical evidence.

Authors:  Wenjie Sun; Cheng N Leong; Zhen Zhang; Jiade J Lu
Journal:  Radiat Oncol       Date:  2010-04-15       Impact factor: 3.481

10.  MicroRNA Expression in a Readily Accessible Common Hepatic Artery Lymph Node Predicts Time to Pancreatic Cancer Recurrence Postresection.

Authors:  Hai V Nguyen; Jesse Gore; Xin Zhong; Sudha S Savant; Samantha Deitz-McElyea; C Max Schmidt; Michael G House; Murray Korc
Journal:  J Gastrointest Surg       Date:  2016-07-25       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.